1Samuel D, Ichai P, Feray C, et al. Neurological improvement during bioartifieiat liver sessions in patients with acute liver failure awaiting transplantation. Transplantation, 2002,73 : 257-264.
2Morsiani E, Pazzi P, Puviani AC, et al. Early Experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. IntJ Artif Organs, 2002,25:192-202.
3Wang PP,Wang JH, Yan ZP, et al. Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction. Biochem Biophys Res Commun, 2004,320:712-716.
4Grompe M. Pancreatic-hepatic switches in vivo. Mech Dev, 2003,120 : 99-106.
5Sekaric P, Cherry J J, Androphy EJ. Binding of HPV 16 E6 to E6AP is not required for activation of hTERT. J Virol, 2007,10: 1128.
6Blasco MA. Telomeres and human disease: Ageing, cancer and beyond. Nat Rev Genet,2005,6:611-622.
7Blackburn EH. Telomeres and telomerase:Their mechanisms of action and the effects of altering their functions. FEBS Lett, 2005,579 : 859-862.
8Daibata M, Taguchi T, Nemoto Y, et al. In vitm Epstein Barr virus-inmaortalized lymphoma cell line carrying t (9; 14) (p13 : q32) chromosome abnormality, de rived from splenic lymphoma with villous lymphocyte. Int J Cancer, 2006, 118: 513-517.
9Shay JW, Wright WE. Senescence and immortalization: Role of telomeres and telomerase. Carcinogenesis, 2005, 26: 867-874.
10Takamasa W, Norikuni S, Westerman KA,et al. Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. Transplantation, 2003, 75 : 1873-1880.
